Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 12,059

Document Document Title
WO/2018/185348A1
The invention relates to a pharmaceutical composition based on a highly pure aqueous solution of chlorine dioxide for use in the local or systemic treatment of acute intoxication caused by toxic substances from plants, mushrooms, aquatic...  
WO/2018/181987A1
Provided is an adsorbent for indole and derivatives thereof that selectively adsorbs indole and derivatives thereof (particularly indole). A copolymer synthesized by mixing structural units based on each monomer at an optimal ratio was d...  
WO/2018/181345A1
Provided is a compound which has an Nrf2-activating activity and is expected to be useful as a prophylactic or therapeutic agent for diseases associated with oxidative stress, particularly hepatitis (e.g., non-alcoholic steatohepatitis (...  
WO/2018/172998A1
The invention provides a composition rich in flavonoids based on natural extracts, comprising a flavonoid extract dispersed by melt mixing or extrusion and encapsulated in a polymer matrix. The invention is also a novel dietary supplemen...  
WO/2018/169055A1
It is known that foods containing a carbohydrate, e.g., starch, in a large amount generate acrylamide upon heating at high temperatures. Some documents state that acrylamide is formed by the Maillard reaction of an amino acid, e.g., aspa...  
WO/2018/170410A1
The disclosure provides chemical compounds possessing therapeutic and/or protective properties against oxidative damage. Methods of making such therapeutic and/or protective compounds and associated compositions are also provided, as are...  
WO/2018/165780A1
Compositions comprising oil palm phenolics and shikimic acid or derivatives thereof and their use in enhancing anti-oxjdative and anti-inflammatory properties.  
WO/2018/162581A1
The present invention relates to desmethylanethole trithione ( AOX ) and derivatives thereof, especially derivatives of formula (I), for the prevention and treatment of diseases whose initiation and/or evolution relates to the production...  
WO/2018/159852A1
The purpose of the present invention is to provide a curcumin-containing solid composition which can be used as a composition for treatment or prevention of disorders or symptoms in which intracellular absorption of curcumin is beneficia...  
WO/2018/153334A1
The present invention provides a biflavonoid-nickel complex and a preparation method and application thereof. The present invention uses amentoflavone as a ligand and a nickel ion as a central ion for reaction to obtain an amentoflavone-...  
WO/2018/153325A1
Disclosed are a biflabonoid-cobalt complex, a preparation method for same, and applications thereof. The present invention has amentoflavone as a ligand and a cobalt ion as a central ion, produces an amentoflavone-cobalt complex via a re...  
WO/2018/153328A1
Disclosed are a biflavonoid-iron complex, a preparation method therefor and use thereof. In the present invention, the amentoflavone-iron complex is obtained by the reaction of the amentoflavone as a ligand and iron ions as central ions,...  
WO/2018/153330A1
Disclosed in the present invention are a biflavonoid-copper complex, a preparation method and an application thereof. In the present invention, amentoflavone is used as a ligand and a copper ion is used as a central ion, an amentoflavone...  
WO/2018/153333A1
The present invention provides a biflavonoid-manganese complex and a preparation method and application thereof. The present invention uses amentoflavone as a ligand and a manganese ion as a central ion for reaction to obtain an amentofl...  
WO/2018/153331A1
The invention discloses a biflavone-zinc complex as well as a preparation method therefor and a use thereof. The invention takes amentoflavone as a ligand, zinc ion as a central ion, and amentoflavone-zinc complex is obtained through rea...  
WO/2018/148788A1
The present invention relates to methods for predicting a risk and a rate of amyloid deposition and plaque formation which relates a correlation between brain iron load and amyloid deposition and plaque formation. The invention also rela...  
WO/2018/152283A1
Water-soluble nanoceria are described herein along with methods of making and using the same. Water-soluble nanoceria described herein comprise a cerium oxide nanoparticle and glycol chitosan. In some embodiments, water-soluble nanoceria...  
WO/2018/145664A1
A composition, comprising a first component --- Cistanche tubulosa extract and a second component --- an oxidized coenzyme (Q10) and/or a reduced coenzyme (QH). The weight ratio of the two components is: first component:second component=...  
WO/2018/145105A1
A method of diminishing the appearance of or effecting the removal or disappearance of seborrheic keratoses by the application of compositions containing a) one or more, preferably a combination of, dietary antioxidants and/or antioxidan...  
WO/2018/142328A1
The present invention relates to a composition comprising quercetin, prunus cerasus dry extract and vitamin C. The invention further relates to the use of the composition in maintaining the levels of uric acid and/or in the prevention an...  
WO/2018/140383A9
A composition for improving the health of a subject in a manner comparable to a bowl of homemade chicken soup is provided. The composition may include n-acetyl cysteine, vitamin C, and one or more carotenoids. The composition may be desi...  
WO/2018/139404A1
As a technique for effectively treating or preventing radiation sickness associated with exposure to radiation, a therapeutic or prophylactic agent for radiation sickness associated with exposure to radiation and others are provided, whe...  
WO/2018/140383A1
A composition for improving the health of a subject in a manner comparable to a bowl of homemade chicken soup is provided. The composition may include n-acetyl cysteine, vitamin C, and one or more carotenoids. The composition may be desi...  
WO/2018/134783A1
Described herein are methods for reducing the risks of exposure to air pollutants, comprising nasally administering to a subject in need thereof a composition that counteracts the effects of one or more air pollutants, wherein the compos...  
WO/2018/129411A1
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...  
WO/2018/124067A1
The present application provides: a radiation damage protective agent characterized by containing, as an active ingredient, hydrogen gas for treating or alleviating radiation damage suffered by a human patient who has experienced radiati...  
WO/2018/121881A1
The invention relates to the use of at least one glycyrrhiza plant-based preparation, chosen from the group comprising: meal from a whole dried glycyrrhiza plant; meal from leaves of the dried glycyrrhiza plant; meal from roots of the dr...  
WO/2018/117014A1
An ophthalmic composition which comprises (A) one or more member selected from (A-1) vitamin A and (A-2) vitamin E and (B) nonionic surfactants and has a transmittance of 70% or higher, wherein the compositional mass ratio of the above i...  
WO/2018/115377A9
The present invention relates to a combination comprising at least an immunocytokine comprising at least a primary binding protein or peptide and a cytokine, fused or conjugated to one another, and a secondary binding molecule capable of...  
WO/2018/113145A1
Provided is a method for preparing human pluripotent stem cells for resisting both cellular senescence and malignant transformation. Genetically enhanced stem cells having increased resistance to adverse situations are obtained by mutati...  
WO/2018/117186A1
The present invention relates to a crystals of glutathione trisulfide dihydrate and a method for producing the same. According to the present invention, for example, by concentrating a solution in which glutathione trisulfide is dissolve...  
WO/2018/112574A1
The present invention describes a process for obtaining bioactive compounds from passion fruit [Passiflora edulis sp) skin. The process is pressurized liquid extraction (PLE) for recovering an extract rich in phenolic compounds such as o...  
WO/2018/115377A1
The present invention relates to a combination comprising at least an immunocytokine comprising at least a primary binding protein or peptide and a cytokine, fused or conjugated to one another, and a secondary binding molecule capable of...  
WO/2018/098553A1
A method of making an antibody in plants that binds to ricin is described. The method comprises (a) introducing a nucleic acid molecule encoding a heavy chain variable region of the antibody and a nucleic acid molecule encoding a light c...  
WO/2018/099493A1
Tropaeolum majus granules and a preparation method therefor. Said granules comprise in parts by weight: 10 to 20 parts of Tropaeolum majus, 3 to 8 parts of Glebionis coronaria, 3 to 5 parts of superfine powder of the stem and leaf of swe...  
WO/2018/100178A1
The invention provides a method for the production of a zeolite particle composition which has optimized characteristics, such as enhanced adsorption and specific ion exchange properties. A method and an apparatus for producing improved ...  
WO/2018/089752A1
The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present i...  
WO/2018/081858A1
The present invention relates to new desferrioxamine B analogues that are useful for iron-chelation therapy, to their preparation including intermediates, and to compositions including the compounds. The present invention also relates to...  
WO/2018/081903A1
There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment th...  
WO/2018/079832A1
The present invention addresses the problem of providing an agent for reducing uremic substances in the blood which has an action of effectively lowering (reducing) the concentration of uremic substances in the blood, and a prophylactic ...  
WO/2018/079702A1
The present invention provides a lactoferrin fusion protein having high clinical utility and a production method therefor. The present invention further provides: a lactoferrin fusion protein that retains the biological activity of nativ...  
WO/2018/077312A1
Disclosed is an effervescent tablet for enhancing immunity, said effervescent tablet comprising the following components in parts by weight: 50-200 parts of vitamin C sodium, 10-30 parts of taurine, 10-30 parts of zinc gluconate, and 10-...  
WO/2018/079178A1
A refined chlorogenic acid-containing composition manufacturing method including a contact step in which a chlorogenic acid-containing composition with a solid content concentration of 1.5-4.7 mass% and a mass ratio of caffeine/chlorogen...  
WO/2018/075641A1
The present invention relates to methods for attenuating aging, of health maintenance, and/or treating, or delaying the onset of, an age-related condition or disorder, in a subject comprising administering to the subject an effective amo...  
WO/2018/071323A1
A method for assessing susceptibility to nausea of a patient comprises assessing the GSH recycling dependent antioxidant activity of the patient's blood cells prior to receiving an emetogenic agent, e.g., a cytostatic agent or a surgical...  
WO/2018/063010A9
The invention relates to a novel lupeol derivative, which is the ester of 4-picolinic acid (isonicotinic acid) and 20(29)-lupen-3.beta.-ol (lupeol), having structural Formula (1). The novel lupeol derivative is a result of modification o...  
WO/2018/063010A1
The invention relates to a novel lupeol derivative, which is the ester of 4-picolinic acid (isonicotinic acid) and 20(29)-lupen-3.beta.-ol (lupeol), having structural Formula (1). The novel lupeol derivative is a result of modification o...  
WO/2018/059922A1
The present invention relates to a film-coated swallowable tablet comprising deferasirox in an amount of at least 60% by weight based on the total weight of the tablet and poloxamer, wherein the weight ratio of deferasirox to poloxamer i...  
WO/2018/053397A1
The invention relates to methods of treating or preventing organophosphate poisoning in a subject in need thereof, comprising administering to the subject isoflurane, enflurane, halothane, sevoflurane, desflurane, xenon or argon in a the...  
WO/2018/050938A1
The invention relates to a pre-loaded injectable device comprising or consisting of the composition according to the invention, the injectable pharmaceutical form, the combined preparation, or the pre-loaded injectable device for treatin...  

Matches 1 - 50 out of 12,059